Gerber Kawasaki Wealth & Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,430
Closed -$215K 371
2026
Q1
$215K Buy
3,430
+348
+11% +$27.8K 0.01% 322
2025
Q4
$294K Buy
3,082
+139
+5% +$13.6K 0.01% 285
2025
Q3
$287K Buy
2,943
+232
+9% +$24K 0.01% 277
2025
Q2
$291K Buy
2,711
+99
+4% +$10K 0.01% 261
2025
Q1
$264K Buy
2,612
+130
+5% +$13.1K 0.01% 264
2024
Q4
$222K Buy
+2,482
New +$218K 0.01% 264
2021
Q4
Sell
-1,500
Closed -$65K 400
2021
Q3
$65K Buy
+1,500
New +$66.4K 0.01% 287

Other funds holding BSX

Gerber Kawasaki Wealth & Investment Management's BSX Position: Q2 2026 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,430 shares — an estimated $215K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in BSX in Q3 2021 and held it in 7 quarters. The position peaked at $294K in Q4 2025. 1,092 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 3,430 Boston Scientific shares in Q2 2026, an estimated $215K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Boston Scientific in Q3 2021 and held it in 7 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Boston Scientific position peaked at $294K in Q4 2025.
  • 1,092 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.